FMS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 Mai 2024 @ 22:00):

Stats
Tagesvolumen	232 364
Durchschnittsvolumen	460 157
Marktkapitalisierung	12.71B
EPS	$0 ( 2024-02-20 )
Nächstes Ertragsdatum	( $0.260 ) 2024-05-14
Last Dividend	$0.618 ( 2023-05-17 )
Next Dividend	$0 ( N/A )
P/E	23.80
ATR14	$0.0100 (0.05%)

Volumen Korrelation

Lang: 0.58 (weak)

Kurz: 0.65 (moderate)

Signal:(71.829) Neutral

Fresenius Medical Care AG Korrelation

10 Am meisten positiv korreliert
DMYS	0.973
CXAC	0.97
ALCC	0.962
AFTR	0.96
BMAC	0.96
MTVC	0.959
MTH	0.959
TRCA	0.958
BSAQ	0.957
PNTM	0.957

10 Am meisten negativ korreliert
GRUB	-0.954
PAK	-0.953
CCOR	-0.94
UNL	-0.936
TPL	-0.936
DBMF	-0.933
RSF	-0.931
UNG	-0.931
GAZ	-0.931
RKLY	-0.93

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Fresenius Medical Care AG Korrelation - Währung/Rohstoff

0.15
( neutral )

-0.67
( moderate negative )

0.00
( neutral )

0.16
( neutral )

0.63
( weak )

0.22
( neutral )

Fresenius Medical Care AG Finanzdaten

Annual	2023
Umsatz:	$19.45B
Bruttogewinn:	$4.93B (25.32 %)
EPS:	$1.700

FY	2023
Umsatz:	$19.45B
Bruttogewinn:	$4.93B (25.32 %)
EPS:	$1.700

FY	2022
Umsatz:	$19.40B
Bruttogewinn:	$5.31B (27.37 %)
EPS:	$2.30

FY	2021
Umsatz:	$17.62B
Bruttogewinn:	$5.08B (28.82 %)
EPS:	$1.655

Financial Reports:

No articles found.

Fresenius Medical Care AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.618 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Fresenius Medical Care AG Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.17 - Stable (3.40%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0930	1998-06-08
Last Dividend	$0.618	2023-05-17
Next Dividend	$0	N/A
Payout Date	2023-06-01
Next Payout Date	N/A
# dividends	27	--
Total Paid Out	$10.47	--
Avg. Dividend % Per Year	1.85%	--
Score	3.94	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.17
Div. Directional Score	8.11	--

Next Divdend (Est)
(2025-04-02)

$0.626 Estimate 3.12 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.94

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
1998	$0.0930	0.85%
1999	$0.104	0.86%
2000	$0.111	0.80%
2001	$0.121	0.87%
2002	$0.125	1.21%
2003	$0.168	2.48%
2004	$0.253	2.11%
2005	$0.239	1.79%
2006	$0.244	1.35%
2007	$0.314	1.39%
2008	$0.416	1.58%
2009	$0.375	1.57%
2010	$0.408	1.50%
2011	$0.475	1.65%
2012	$0.456	1.30%
2013	$0.490	1.43%
2014	$0.533	1.53%
2015	$0.438	1.20%
2016	$0.440	1.07%
2017	$0.514	1.21%
2018	$0.632	1.21%
2019	$0.655	2.01%
2020	$0.707	1.91%
2021	$0.834	1.96%
2022	$0.709	2.17%
2023	$0.618	3.84%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0281	1.500	9.44	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0161	1.200	9.46	10.00	[0 - 0.3]
returnOnEquityTTM	0.0398	1.500	-0.669	-1.004	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.424	0.800	7.88	6.30	[1 - 3]
quickRatioTTM	0.916	0.800	9.32	7.45	[0.8 - 2.5]
cashRatioTTM	0.230	1.500	9.84	10.00	[0.2 - 2]
debtRatioTTM	0.355	-1.500	4.08	-6.12	[0 - 0.6]
interestCoverageTTM	3.47	1.000	9.83	9.83	[3 - 30]
operatingCashFlowPerShareTTM	8.96	2.00	7.01	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.63	2.00	6.69	10.00	[0 - 20]
debtEquityRatioTTM	0.885	-1.500	6.46	-9.69	[0 - 2.5]
grossProfitMarginTTM	0.253	1.000	9.11	9.11	[0.2 - 0.8]
operatingProfitMarginTTM	0.0710	1.000	-0.580	-0.580	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.218	1.000	9.90	9.90	[0.2 - 2]
assetTurnoverTTM	0.573	0.800	9.51	7.61	[0.5 - 2]
Total Score				11.04

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.83	1.000	9.01	0	[1 - 100]
returnOnEquityTTM	0.0398	2.50	-0.430	-1.004	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.63	2.00	7.79	10.00	[0 - 30]
dividendYielPercentageTTM	3.31	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.96	2.00	7.01	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.535	1.500	3.10	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.135	1.000	9.12	0	[0.1 - 0.5]
Total Score				5.17

Fresenius Medical Care AG

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.